drugset / Trial / NCT04893798

A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen

NCT04893798

Phase 1 Completed 67 enrolled Pfizer
RandomizedParallel-groupOpen-labelOther

Summary

The purpose of the study is to compare the pharmacokinetics and relative bioavailability of medroxyprogesterone in healthy female participants following subcutaneous injection of Sayana Press into the upper arm versus anterior thigh and abdomen.

Timeline

Start
2021-09-16
Primary completion
2025-07-24
Completion
2025-07-24

Drugs

EvaluationDrugModalityDoseRoute
Subject medroxyprogesterone acetate Other / unclassified Subcutaneous

Indications

No indication recorded.